SCYNEXIS, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SCYNEXIS, Inc. (SCYX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $4.99 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2021-11-10
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-09-30 was $3.78M, a 250.93% increase year-over-year.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was $1.28M, a 480.09% increase year-over-year.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was -$68.00K.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-12-31 was $461.00K, a 83.94% decline year-over-year.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was -$2.30M, a 144.03% decline from fiscal 2019.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $5.21M, a 2281.28% increase from fiscal 2018.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $219.00K, a 89.46% decline from fiscal 2017.
- SCYNEXIS, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $2.08M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.06M derived: sum of 2 quarters · filed 2021-11-10 | $4.99M 10-Q · filed 2021-11-10 | $5.45M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2021-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.21M 10-Q · filed 2021-08-16 | $1.68M derived: sum of 3 quarters · filed 2021-08-16 | $2.75M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2021-03-31 | -$68.00K 10-Q · filed 2021-05-17 | $393.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.47M derived: sum of 3 quarters · filed 2021-11-10 | $1.69M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.54M derived: sum of 2 quarters · filed 2021-11-10 | $1.76M derived: sum of 3 quarters · filed 2021-11-10 | -$2.30M 10-K · filed 2021-03-29 | ||||
| 2020-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.30M derived: sum of 2 quarters · filed 2021-11-10 | -$2.76M 10-Q · filed 2021-11-10 | $113.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$3.83M 10-Q · filed 2021-08-16 | -$963.00K derived: sum of 3 quarters · filed 2021-08-16 | -$106.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$4.05M 10-Q · filed 2021-05-17 | -$1.18M derived: sum of 2 quarters · filed 2021-05-17 | -$327.00K derived: sum of 3 quarters · filed 2021-05-17 | $2.53M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $3.73M derived: sum of 2 quarters · filed 2021-03-29 | $6.58M derived: sum of 3 quarters · filed 2021-03-29 | $5.21M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $857.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.71M derived: sum of 2 quarters · filed 2020-11-06 | $2.35M 10-Q · filed 2020-11-06 | $4.73M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.49M 10-Q · filed 2020-08-10 | $3.88M derived: sum of 3 quarters · filed 2020-08-10 | $3.04M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$1.37M 10-Q · filed 2020-05-11 | $1.02M derived: sum of 2 quarters · filed 2020-05-11 | $184.00K derived: sum of 3 quarters · filed 2020-05-11 | $352.00K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.55M derived: sum of 2 quarters · filed 2020-03-11 | $1.72M derived: sum of 3 quarters · filed 2020-03-11 | $219.00K 10-K · filed 2020-03-11 | $223.00K 10-K · filed 2019-03-14 | |||
| 2018-09-30 | -$837.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$669.00K derived: sum of 2 quarters · filed 2019-11-12 | -$2.17M 10-Q · filed 2019-11-12 | -$2.17M 10-Q · filed 2018-11-13 | -$183.00K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$1.33M 10-Q · filed 2019-08-07 | -$1.33M 10-Q · filed 2018-08-09 | $654.00K derived: sum of 3 quarters · filed 2019-08-07 | $1.16M derived: sum of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | -$1.50M 10-Q · filed 2019-05-08 | -$1.50M 10-Q · filed 2018-05-08 | $486.00K derived: sum of 2 quarters · filed 2019-05-08 | $989.00K derived: sum of 3 quarters · filed 2019-05-08 | $937.00K derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.49M derived: sum of 2 quarters · filed 2019-03-14 | $2.44M derived: sum of 3 quarters · filed 2019-03-14 | $2.08M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $503.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $451.00K derived: sum of 2 quarters · filed 2018-11-13 | $92.00K 10-Q · filed 2018-11-13 | -$222.00K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$411.00K 10-Q · filed 2018-08-09 | -$725.00K derived: sum of 3 quarters · filed 2018-08-09 | -$998.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$359.00K 10-Q · filed 2018-05-08 | -$673.00K derived: sum of 2 quarters · filed 2018-05-08 | -$946.00K derived: sum of 3 quarters · filed 2018-05-08 | -$854.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | -$314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$587.00K derived: sum of 2 quarters · filed 2018-03-13 | -$495.00K derived: sum of 3 quarters · filed 2018-03-13 | -$309.00K 10-K · filed 2018-03-13 | ||||
| 2016-09-30 | -$273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$181.00K derived: sum of 2 quarters · filed 2017-11-07 | $5.00K 10-Q · filed 2017-11-07 | $1.50M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $278.00K 10-Q · filed 2017-08-08 | $1.77M derived: sum of 3 quarters · filed 2017-08-08 | $877.00K derived: sum of 4 quarters · filed 2017-08-08 | ||||
| 2016-03-31 | $186.00K 10-Q · filed 2017-05-08 | $1.68M derived: sum of 2 quarters · filed 2017-05-08 | $785.00K derived: sum of 3 quarters · filed 2017-05-08 | $200.00K derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $599.00K derived: sum of 2 quarters · filed 2017-03-13 | $14.00K derived: sum of 3 quarters · filed 2017-03-13 | $1.07M 10-K · filed 2017-03-13 | ||||
| 2015-09-30 | -$898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$1.48M derived: sum of 2 quarters · filed 2016-11-07 | -$431.00K 10-Q · filed 2016-11-07 | $237.00K derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | -$585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $467.00K 10-Q · filed 2016-08-08 | $1.14M derived: sum of 3 quarters · filed 2017-03-13 | $1.49M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $1.05M 10-Q · filed 2016-05-09 | $1.72M derived: sum of 2 quarters · filed 2017-03-13 | $2.07M derived: sum of 3 quarters · filed 2017-03-13 | $1.99M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.02M derived: sum of 2 quarters · filed 2017-03-13 | $940.00K derived: sum of 3 quarters · filed 2017-03-13 | $1.57M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $272.00K derived: sum of 2 quarters · filed 2015-11-13 | $907.00K 10-Q · filed 2015-11-13 | $645.00K derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | -$78.00K derived: 10-Q 6 month − 8-K 3 month · filed 2015-08-19 | $557.00K 10-Q · filed 2015-08-19 | $946.00K 10-Q · filed 2014-08-13 | $295.00K derived: sum of 3 quarters · filed 2015-10-30 | $782.00K derived: sum of 4 quarters · filed 2015-10-30 | |||
| 2014-03-31 | $635.00K 8-K · filed 2015-10-30 | $373.00K derived: sum of 2 quarters · filed 2015-10-30 | $860.00K derived: sum of 3 quarters · filed 2015-10-30 | $792.00K derived: sum of 4 quarters · filed 2015-10-30 | ||||
| 2013-12-31 | -$262.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $225.00K derived: sum of 2 quarters · filed 2015-10-30 | $157.00K derived: sum of 3 quarters · filed 2015-10-30 | -$82.00K 8-K · filed 2015-10-30 | ||||
| 2013-09-30 | $487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $419.00K derived: sum of 2 quarters · filed 2014-11-13 | $180.00K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-13 | -$307.00K 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | -$239.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |